Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nathali Montenegro"'
Autor:
Sanja Mandaric, Heather Friberg, Xavier Saez-Llorens, Charissa Borja-Tabora, Shibadas Biswal, Ian Escudero, Alice Faccin, Raphael Gottardo, Manja Brose, Nicholas Roubinis, Darlene Fladager, Rodrigo DeAntonio, Julie Anne L. Dimero, Nathali Montenegro, Nicolas Folschweiller, Jeffrey R. Currier, Mayuri Sharma, Vianney Tricou
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-13 (2024)
Abstract As robust cellular responses are important for protection against dengue, this phase 2 study evaluated the kinetics and phenotype of T cell responses induced by TAK-003, a live-attenuated tetravalent dengue vaccine, in 4–16-year-old living
Externí odkaz:
https://doaj.org/article/3b801d6feac84345ad976ff7208a2eac
Autor:
Reynaldo Chandler, Nathali Montenegro, Cecilia Llorach, Dean Quinn, Lorena Noriega-Aguirre, Mohammed Bensellam, Nathalie De Schrevel, Sherine Kuriyakose, Axel Lambert, Aurélie Olivier, Veronica Hulstrøm
Publikováno v:
Open Forum Infectious Diseases. 9
Background Respiratory syncytial virus (RSV) can cause severe respiratory disease in older adults (OAs). However, there is no approved vaccine against RSV disease in OAs. Co-administration of vaccines against RSV and influenza could be considered giv
Autor:
Rodrigo DeAntonio, Derek Wallace, Xavier Sáez-Llorens, Maria Vargas, Debbie Mendoza, Onix De Suman, Astrid Borkowski, Inge Lefevre, Martina Rauscher, Manja Brose, Ana Cecilia Villarreal, Suely Tuboi, Nathali Montenegro, Sonia Mazara, Delia Yu, Luis Rivera, Epiphany Dato, Vianney Tricou, José Jimeno
Publikováno v:
Lancet (London, England). 395(10234)
Summary Background An unmet clinical need remains for an effective tetravalent dengue vaccine suitable for all age groups, regardless of serostatus. We assessed the immunogenicity and safety of three different dose schedules of a tetravalent dengue v